Biobanking EMEA Market Size, Industry Trends, and Statistics Report

Biobanking -EMEA Market Status and Trend Report 2013-2023

Report ID: MIReports 7206 | Number of pages: 142 | Publish Date: Jun 2019 | Category: Lifesciences and Healthcare
Report Summary

Biobanking -EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biobanking  industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of Biobanking  2013-2017, and development forecast 2018-2023
Main market players of Biobanking  in EMEA, with company and product introduction, position in the Biobanking  market
Market status and development trend of Biobanking  by types and applications
Cost and profit status of Biobanking , and marketing status
Market growth drivers and challenges

The report segments the EMEA Biobanking  market as:

EMEA Biobanking  Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa

EMEA Biobanking  Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Equipment 
Consumable

EMEA Biobanking  Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Virtual Biobanks 
Tissue Biobanks 
Population Biobanks

EMEA Biobanking  Market: Players Segment Analysis (Company and Product introduction, Biobanking  Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher 
Beckman Coulter 
Panasonic 
SOL Group 
Promega 
Merck 
Greiner Bio One 
Chart Industries 
Brooks Life Science 
Tecan Group 
QIAGEN 
BD 
Lifeline Scientific 
Hamilton 
So-Low 
TTP Labtech Ltd 
Biolife Solutions 
DNA Genotek 
Custom Biogenic Systems 
LVL Technologies 
BioRep

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Interested in this report?
Get your sample now!
Table of Contents
Chapter 1 Overview of Biobanking 
    1.1 Definition of Biobanking  in This Report
    1.2 Commercial Types of Biobanking 
        1.2.1 Equipment 
        1.2.2 Consumable
    1.3 Downstream Application of Biobanking 
        1.3.1 Virtual Biobanks 
        1.3.2 Tissue Biobanks 
        1.3.3 Population Biobanks
    1.4 Development History of Biobanking 
    1.5 Market Status and Trend of Biobanking  2013-2023
        1.5.1 EMEA Biobanking  Market Status and Trend 2013-2023
        1.5.2 Regional Biobanking  Market Status and Trend 2013-2023
Chapter 2 EMEA Market Status and Forecast by Regions
    2.1 Market Status of Biobanking  in EMEA 2013-2017
    2.2 Consumption Market of Biobanking  in EMEA by Regions
        2.2.1 Consumption Volume of Biobanking  in EMEA by Regions
        2.2.2 Revenue of Biobanking  in EMEA by Regions
    2.3 Market Analysis of Biobanking  in EMEA by Regions
        2.3.1 Market Analysis of Biobanking  in Europe 2013-2017
        2.3.2 Market Analysis of Biobanking  in Middle East 2013-2017
        2.3.3 Market Analysis of Biobanking  in Africa 2013-2017
    2.4 Market Development Forecast of Biobanking  in EMEA 2018-2023
        2.4.1 Market Development Forecast of Biobanking  in EMEA 2018-2023
        2.4.2 Market Development Forecast of Biobanking  by Regions 2018-2023
Chapter 3 EMEA Market Status and Forecast by Types
    3.1 Whole EMEA Market Status by Types
        3.1.1 Consumption Volume of Biobanking  in EMEA by Types
        3.1.2 Revenue of Biobanking  in EMEA by Types
    3.2 EMEA Market Status by Types in Major Countries
        3.2.1 Market Status by Types in Europe
        3.2.2 Market Status by Types in Middle East
        3.2.3 Market Status by Types in Africa
    3.3 Market Forecast of Biobanking  in EMEA by Types
Chapter 4 EMEA Market Status and Forecast by Downstream Industry
    4.1 Demand Volume of Biobanking  in EMEA by Downstream Industry
    4.2 Demand Volume of Biobanking  by Downstream Industry in Major Countries
        4.2.1 Demand Volume of Biobanking  by Downstream Industry in Europe
        4.2.2 Demand Volume of Biobanking  by Downstream Industry in Middle East
        4.2.3 Demand Volume of Biobanking  by Downstream Industry in Africa
    4.3 Market Forecast of Biobanking  in EMEA by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Biobanking 
    5.1 EMEA Economy Situation and Trend Overview
    5.2 Biobanking  Downstream Industry Situation and Trend Overview
Chapter 6 Biobanking  Market Competition Status by Major Players in EMEA
    6.1 Sales Volume of Biobanking  in EMEA by Major Players
    6.2 Revenue of Biobanking  in EMEA by Major Players
    6.3 Basic Information of Biobanking  by Major Players
        6.3.1 Headquarters Location and Established Time of Biobanking  Major Players
        6.3.2 Employees and Revenue Level of Biobanking  Major Players
    6.4 Market Competition News and Trend
        6.4.1 Merger, Consolidation or Acquisition News
        6.4.2 Investment or Disinvestment News
        6.4.3 New Product Development and Launch
Chapter 7 Biobanking  Major Manufacturers Introduction and Market Data
    7.1 Thermo Fisher 
        7.1.1 Company profile
        7.1.2 Representative Biobanking  Product
        7.1.3 Biobanking  Sales, Revenue, Price and Gross Margin of Thermo Fisher 
    7.2 Beckman Coulter 
        7.2.1 Company profile
        7.2.2 Representative Biobanking  Product
        7.2.3 Biobanking  Sales, Revenue, Price and Gross Margin of Beckman Coulter 
    7.3 Panasonic 
        7.3.1 Company profile
        7.3.2 Representative Biobanking  Product
        7.3.3 Biobanking  Sales, Revenue, Price and Gross Margin of Panasonic 
    7.4 SOL Group 
        7.4.1 Company profile
        7.4.2 Representative Biobanking  Product
        7.4.3 Biobanking  Sales, Revenue, Price and Gross Margin of SOL Group 
    7.5 Promega 
        7.5.1 Company profile
        7.5.2 Representative Biobanking  Product
        7.5.3 Biobanking  Sales, Revenue, Price and Gross Margin of Promega 
    7.6 Merck 
        7.6.1 Company profile
        7.6.2 Representative Biobanking  Product
        7.6.3 Biobanking  Sales, Revenue, Price and Gross Margin of Merck 
    7.7 Greiner Bio One 
        7.7.1 Company profile
        7.7.2 Representative Biobanking  Product
        7.7.3 Biobanking  Sales, Revenue, Price and Gross Margin of Greiner Bio One 
    7.8 Chart Industries 
        7.8.1 Company profile
        7.8.2 Representative Biobanking  Product
        7.8.3 Biobanking  Sales, Revenue, Price and Gross Margin of Chart Industries 
    7.9 Brooks Life Science 
        7.9.1 Company profile
        7.9.2 Representative Biobanking  Product
        7.9.3 Biobanking  Sales, Revenue, Price and Gross Margin of Brooks Life Science 
    7.10 Tecan Group 
        7.10.1 Company profile
        7.10.2 Representative Biobanking  Product
        7.10.3 Biobanking  Sales, Revenue, Price and Gross Margin of Tecan Group 
    7.11 QIAGEN 
        7.11.1 Company profile
        7.11.2 Representative Biobanking  Product
        7.11.3 Biobanking  Sales, Revenue, Price and Gross Margin of QIAGEN 
    7.12 BD 
        7.12.1 Company profile
        7.12.2 Representative Biobanking  Product
        7.12.3 Biobanking  Sales, Revenue, Price and Gross Margin of BD 
    7.13 Lifeline Scientific 
        7.13.1 Company profile
        7.13.2 Representative Biobanking  Product
        7.13.3 Biobanking  Sales, Revenue, Price and Gross Margin of Lifeline Scientific 
    7.14 Hamilton 
        7.14.1 Company profile
        7.14.2 Representative Biobanking  Product
        7.14.3 Biobanking  Sales, Revenue, Price and Gross Margin of Hamilton 
    7.15 So-Low 
        7.15.1 Company profile
        7.15.2 Representative Biobanking  Product
        7.15.3 Biobanking  Sales, Revenue, Price and Gross Margin of So-Low 
    7.16 TTP Labtech Ltd 
    7.17 Biolife Solutions 
    7.18 DNA Genotek 
    7.19 Custom Biogenic Systems 
    7.20 LVL Technologies 
    7.21 BioRep
Chapter 8 Upstream and Downstream Market Analysis of Biobanking 
    8.1 Industry Chain of Biobanking 
    8.2 Upstream Market and Representative Companies Analysis
    8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Biobanking 
    9.1 Cost Structure Analysis of Biobanking 
    9.2 Raw Materials Cost Analysis of Biobanking 
    9.3 Labor Cost Analysis of Biobanking 
    9.4 Manufacturing Expenses Analysis of Biobanking 
Chapter 10 Marketing Status Analysis of Biobanking 
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Reference

List of Tables

    Table Advantage and Disadvantage of Equipment 
    Table Advantage and Disadvantage of Consumable
    Table Consumption Volume of Biobanking  in EMEA by Regions 2013-2017
    Table Revenue of Biobanking  in EMEA by Regions 2013-2017
    Table Consumption Volume of Biobanking  in EMEA by Regions 2018-2023
    Table Revenue of Biobanking  in EMEA by Regions 2018-2023
    Table Consumption Volume of Biobanking  in EMEA by Types 2013-2017
    Table Revenue of Biobanking  in EMEA by Types 2013-2017
    Table Consumption Volume of Biobanking  by Types in Europe 2013-2017
    Table Consumption Volume of Biobanking  by Types in Middle East 2013-2017
    Table Consumption Volume of Biobanking  by Types in Africa 2013-2017
    Table Consumption Volume Forecast of Biobanking  in EMEA by Types 2018-2023
    Table Revenue Forecast of Biobanking  in EMEA by Types 2018-2023
    Table Demand Volume of Biobanking  in EMEA by Downstream Industry 2013-2017
    Table Demand Volume of Biobanking  by Downstream Industry in Europe 2013-2017
    Table Demand Volume of Biobanking  by Downstream Industry in Middle East 2013-2017
    Table Demand Volume of Biobanking  by Downstream Industry in Africa 2013-2017
    Table Demand Volume Forecast of Biobanking  in EMEA by Downstream Industry 2018-2023
    Table Sales Volume of Biobanking  in EMEA by Major Players 2013-2017
    Table Revenue of Biobanking  in EMEA by Major Players 2013-2017
    Table Headquarters Location and Established Time of Biobanking  Major Players
    Table Employees and Revenue Level of Biobanking  Major Players
    Table Representative Biobanking  Product One of Thermo Fisher 
    Table Representative Biobanking  Product Two of Thermo Fisher 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Thermo Fisher  2013-2017
    Table Representative Biobanking  Product One of Beckman Coulter 
    Table Representative Biobanking  Product Two of Beckman Coulter 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Beckman Coulter  2013-2017
    Table Representative Biobanking  Product One of Panasonic 
    Table Representative Biobanking  Product Two of Panasonic 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Panasonic  2013-2017
    Table Representative Biobanking  Product One of SOL Group 
    Table Representative Biobanking  Product Two of SOL Group 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of SOL Group  2013-2017
    Table Representative Biobanking  Product One of Promega 
    Table Representative Biobanking  Product Two of Promega 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Promega  2013-2017
    Table Representative Biobanking  Product One of Merck 
    Table Representative Biobanking  Product Two of Merck 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Merck  2013-2017
    Table Representative Biobanking  Product One of Greiner Bio One 
    Table Representative Biobanking  Product Two of Greiner Bio One 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Greiner Bio One  2013-2017
    Table Representative Biobanking  Product One of Chart Industries 
    Table Representative Biobanking  Product Two of Chart Industries 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Chart Industries  2013-2017
    Table Representative Biobanking  Product One of Brooks Life Science 
    Table Representative Biobanking  Product Two of Brooks Life Science 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Brooks Life Science  2013-2017
    Table Representative Biobanking  Product One of Tecan Group 
    Table Representative Biobanking  Product Two of Tecan Group 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Tecan Group  2013-2017
    Table Representative Biobanking  Product One of QIAGEN 
    Table Representative Biobanking  Product Two of QIAGEN 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of QIAGEN  2013-2017
    Table Representative Biobanking  Product One of BD 
    Table Representative Biobanking  Product Two of BD 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of BD  2013-2017
    Table Representative Biobanking  Product One of Lifeline Scientific 
    Table Representative Biobanking  Product Two of Lifeline Scientific 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Lifeline Scientific  2013-2017
    Table Representative Biobanking  Product One of Hamilton 
    Table Representative Biobanking  Product Two of Hamilton 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of Hamilton  2013-2017
    Table Representative Biobanking  Product One of So-Low 
    Table Representative Biobanking  Product Two of So-Low 
    Table Biobanking  Sales, Revenue, Price and Gross Margin of So-Low  2013-2017